Orca Bio

United States
New Lisbon, Wisconsin, United States, 94025

Company profile

Orca Bio company profile

Orca Bio is a clinical-stage cell therapy company dedicated to delivering curative medicine to patients. Orca Bio has developed a pipeline of proprietary technologies that have the potential to impact over 100 malignant and auto-immune diseases. Orca has assembled a team of world-leading experts and technologists to execute this vision.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
251-500 employees
Revenue range
$1M-$10M
Founded
2016-01-01, Year

Headquarters

Postal code
94025
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Late Stage Venture
Funding rounds
5
Total equity funding
$442M
Last funding
Series F / $250M / 2026-01-09
Last equity funding
Series F / $250M
Investors
13
Lead investors
2
Founders
4
Articles
100

Founders and investors

Founders

Ivan DimovJeroen BekaertNathaniel FernhoffRonald Martell

Lead investors

Lightspeed Venture PartnersSilicon Valley Bank

Investors

8VCDCVC BioFelicisLightspeed Venture PartnersMubadala